SASB Content Index

Sustainability Disclosure Topics and Accounting Metrics

Topic Accounting Metric Code Disclosure Location
Fleet Fuel Management Payload fuel economy HC-DI-110a.1 Integrated Report 2021, pages 70-71
Description of efforts to reduce the environmental impact of logistics HC-DI-110a.2 Integrated Report 2021, pages 25, 71
Product Safety Total amount of monetary losses as a result of legal proceedings associated with product safety HC-DI-250a.1 N/A
Description of efforts to minimize health and safety risks of products sold associated with toxicity/chemical safety, high abuse potential, or delivery HC-DI-250a.2 Integrated Report 2021, pages 16-17, 59-60
Counterfeit Drugs Description of methods and technologies used to maintain traceability of products throughout the distribution chain and prevent counterfeiting HC-DI-260a.1 Integrated Report 2021, pages 59-60
Discussion of due diligence process to qualify suppliers of pharmaceuticals and medical equipment and devices HC-DI-260a.2 Integrated Report 2021, pages 59-60
Discussion of process for alerting customers and business partners of potential or known risks associated with counterfeit products HC-DI-260a.3 Integrated Report 2021, pages 59-60
Product Lifecycle Management Discussion of strategies to reduce the environmental impact of packaging throughout its lifecycle HC-DI-410a.1 HOME > CSR Information > CSR Initiatives > Environmental Initiatives
Amount (by weight) of products accepted for take-back and reused, recycled, or donated HC-DI-410a.2 HOME > CSR Information > CSR Initiatives > Environmental Initiatives
Business Ethics Description of efforts to minimize conflicts of interest and unethical business practices HC-DI-510a.1 Integrated Report 2021, pages 56-58
Total amount of monetary losses as a result of legal proceedings associated with bribery, corruption, or other unethical business practices HC-DI-510a.2 N/A

Activity Metrics

Topic Code Disclosure Location
Number of pharmaceutical units sold by product category HC-DI-000.A Currently, sales volume of pharmaceuticals by product category is not disclosed, but net sales by product type is disclosed.
Data Book for the Year Ended March 31, 2021, page 7
Number of medical devices sold by product category HC-DI-000.B Currently, sales volume of pharmaceuticals by product category is not disclosed, but net sales by product type is disclosed.
Data Book for the Year Ended March 31, 2021, page 7